Toru Nishikawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Toru Nishikawa has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Naoki Yamamoto
Sec. of Psych. and Bahav. Neurosci., Tokyo Med. and Dent. Univ., Tokyo, Japan
2 shared publicationsAkeo Kurumaji
1 shared publication- Akihito Uezato
Center for Basic Medical Research, International University of Health and Welfare, Tochigi, Japan
1 shared publication Asami Umino
Section of Psychiatry and Behavioral Sciences, Tokyo Medical and Dental University, Tokyo, Japan
1 shared publicationDai Shimazu
Sec. of Psych. and Bahav. Neurosci., Tokyo Med. and Dent. Univ., Tokyo, Japan
1 shared publicationHidenori Atsuta
1 shared publication
Latest Publications
- 30 September 2011
- Published by Elsevier in Neuroscience Research
- Vol. 71, e213
Decreasing effects of an AMPA receptor agonist and zinc ion on the extracellular d-serine contents in the medial frontal cortex of the rat
- 30 September 2011
- Published by Elsevier in Neuroscience Research
- Vol. 71, e213
Decreasing effects of an AMPA receptor agonist and zinc ion on the extracellular d-serine contents in the medial frontal cortex of the rat
- 30 September 2011
- Published by Elsevier in Neuroscience Research
- Vol. 71, e301
Genetic association and postmortem studies of D-serine modulator PAPST1 in schizophrenia
- 30 September 2011
- Published by Elsevier in Neuroscience Research
- Vol. 71, e301
Genetic association and postmortem studies of D-serine modulator PAPST1 in schizophrenia
- 1 January 2010
- Vol. 112 (2) , 97-110
[A case of thiamine deficiency with psychotic symptoms--blood concentration of thiamine and response to therapy].
We report the case of a 63-year-old woman with thiamine deficiency who showed auditory hallucinations, a delusion of persecution, catatonic stupor, and catalepsy but no neurological symptoms including oculomotor or gait disturbance. Brain MRI did not show high-intensity T2 signals in regions including the thalami, mamillary bodies, or periaqueductal area. Her thiamine concentration was 19 ng/mL, only slightly less than the reference range of 20-50 ng/mL. Her psychosis was unresponsive to antipsychotics or electroconvulsive therapy, but was ameliorated by repetitive intravenous thiamine administrations at 100-200 mg per day. However, one month after completing intravenous treatment, her psychosis recurred, even though she was given 150 mg of thiamine per day orally and her blood concentration of thiamine was maintained at far higher than the reference range. Again, intravenous thiamine administration was necessary to ameliorate her symptoms. The present patient indicates that the possibility of thiamine deficiency should be considered in cases of psychosis without neurological disturbance and high-intensity T2 MRI lesions. Also, this case suggests that a high blood thiamine concentration does not necessarily correspond to sufficient thiamine levels in the brain. Based on this, we must reconsider the importance of a high dose of thiamine administration as a therapy for thiamine deficiency. The validity of the reference range of the thiamine concentration, 20-50 ng/mL, is critically reviewed.
- 1 January 2010
- Vol. 112 (2) , 97-110
[A case of thiamine deficiency with psychotic symptoms--blood concentration of thiamine and response to therapy].
We report the case of a 63-year-old woman with thiamine deficiency who showed auditory hallucinations, a delusion of persecution, catatonic stupor, and catalepsy but no neurological symptoms including oculomotor or gait disturbance. Brain MRI did not show high-intensity T2 signals in regions including the thalami, mamillary bodies, or periaqueductal area. Her thiamine concentration was 19 ng/mL, only slightly less than the reference range of 20-50 ng/mL. Her psychosis was unresponsive to antipsychotics or electroconvulsive therapy, but was ameliorated by repetitive intravenous thiamine administrations at 100-200 mg per day. However, one month after completing intravenous treatment, her psychosis recurred, even though she was given 150 mg of thiamine per day orally and her blood concentration of thiamine was maintained at far higher than the reference range. Again, intravenous thiamine administration was necessary to ameliorate her symptoms. The present patient indicates that the possibility of thiamine deficiency should be considered in cases of psychosis without neurological disturbance and high-intensity T2 MRI lesions. Also, this case suggests that a high blood thiamine concentration does not necessarily correspond to sufficient thiamine levels in the brain. Based on this, we must reconsider the importance of a high dose of thiamine administration as a therapy for thiamine deficiency. The validity of the reference range of the thiamine concentration, 20-50 ng/mL, is critically reviewed.
- 1 January 2003
- No. 40
[Cocaine-related mental disorders].
- 1 January 1996
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 38 (1) , 77-86
Synthesis and evaluation of new 18F-labelled thienylcyclohexylpiperidine (TCP) analogues as radioligands for the NMDA receptor‐channel complex
- 1 January 1996
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 38 (1) , 77-86
Synthesis and evaluation of new 18F-labelled thienylcyclohexylpiperidine (TCP) analogues as radioligands for the NMDA receptor‐channel complex